Back to Gastroenterology
Gastroenterologyv1978Evidence-Based

Manning Criteria for Diagnosis of Irritable Bowel Syndrome (IBS)

Determines likelihood of irritable bowel syndrome diagnosis based on six clinically significant criteria related to abdominal pain and stool characteristics. Developed in 1978 from study of 109 patients with abdominal symptoms. Requires at least 3 of 6 criteria to suggest IBS diagnosis.

Clinical Input Parameters

years
Range: 10 — 100 years
Clinical Assessment
Awaiting Parameters
manning criteria score
—criteria
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Manning Criteria for Diagnosis of Irritable Bowel Syndrome (IBS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Manning Criteria Score = Sum of positive criteria (pain onset with frequent BM + looser stools with pain + pain relief with defecation + abdominal bloating + incomplete evacuation + diarrhea with mucus). Score ≥3 suggests IBS if no red flags present (age >50, weight loss, blood in stools, anemia, fever).

Clinical Pearls & Practice Notes

  • Developed in 1978 by Manning et al. from study of 109 patients with abdominal symptoms
  • Sensitivity ranges from 63-90%, specificity from 70-93% depending on study population
  • More specific than Rome criteria but less sensitive for IBS diagnosis
  • Red flag symptoms (age >50, weight loss, blood in stools, anemia, fever) invalidate diagnosis
  • Should be used in conjunction with clinical judgment and appropriate investigations
  • Rome IV criteria are more current and widely used for IBS diagnosis
  • Requires exclusion of organic gastrointestinal disease through appropriate testing
  • Not suitable as sole diagnostic tool - clinical assessment and red flag evaluation essential
  • Consider inflammatory markers, celiac serology, and colonoscopy in appropriate patients
  • Functional bowel disorders diagnosis of exclusion requiring systematic evaluation

Evidence & Literature Citations

  1. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J. 1978 Sep 2;2(6138):653-4. doi: 10.1136/bmj.2.6138.653.
  2. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 2000 Jan;46(1):78-82. doi: 10.1136/gut.46.1.78.
  3. Drossman DA, Chang L, Bellamy N, Gallo-Torres HE, Lembo A, Mearin F, et al. Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol. 2011 Oct;106(10):1749-59. doi: 10.1038/ajg.2011.201.

Score Interpretation Ranges

IBS Unlikely0 – 2 pts

Insufficient criteria for IBS diagnosis

IBS Likely3 – 6 pts

Sufficient criteria for IBS diagnosis if no red flags present

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.